ArticleHealthcare (Basel, Switzerland)2022

Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators.

Hamu J Mlyuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.